BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38330995)

  • 1. Definition, Epidemiology, and Pathogenesis of Severe Community-Acquired Pneumonia.
    Cavallazzi R; Ramirez JA
    Semin Respir Crit Care Med; 2024 Apr; 45(2):143-157. PubMed ID: 38330995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.
    Laterre PF; Garber G; Levy H; Wunderink R; Kinasewitz GT; Sollet JP; Maki DG; Bates B; Yan SC; Dhainaut JF;
    Crit Care Med; 2005 May; 33(5):952-61. PubMed ID: 15891319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia: still a major burden of disease.
    Feldman C; Anderson R
    Curr Opin Crit Care; 2016 Oct; 22(5):477-84. PubMed ID: 27583588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia.
    Blanc E; Chaize G; Fievez S; Féger C; Herquelot E; Vainchtock A; Timsit JF; Gaillat J
    BMC Infect Dis; 2021 Sep; 21(1):949. PubMed ID: 34521380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity assessment in community-acquired pneumonia.
    Ewig S; Schäfer H; Torres A
    Eur Respir J; 2000 Dec; 16(6):1193-201. PubMed ID: 11292126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired pneumonia in the elderly: a practical guide to treatment.
    Lieberman D; Lieberman D
    Drugs Aging; 2000 Aug; 17(2):93-105. PubMed ID: 10984198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.
    Lin FM; Feng JY; Fang WF; Wu CL; Yu CJ; Lin MC; Ku SC; Chen CW; Tu CY; Yang KY
    J Microbiol Immunol Infect; 2019 Apr; 52(2):320-328. PubMed ID: 30245205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcome of healthcare associated pneumonia in Turkey.
    Gündüz C; Taşbakan MS; Sayıner A; Çilli A; Kılınç O; Şakar Coşkun A
    Tuberk Toraks; 2016 Sep; 64(3):185-190. PubMed ID: 28393724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel targets in the management of pneumonia.
    Díaz LA; Mortensen EM; Anzueto A; Restrepo MI
    Ther Adv Respir Dis; 2008 Dec; 2(6):387-400. PubMed ID: 19124384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults.
    Choi SH; Hong SB; Huh JW; Jung J; Kim MJ; Chong YP; Kim SH; Sung H; Koo HJ; Do KH; Lee SO; Lim CM; Kim YS; Woo JH; Koh Y
    J Clin Virol; 2019 Aug; 117():1-4. PubMed ID: 31128379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes in Severe Community-Acquired Pneumonia.
    Carella F; Aliberti S; Stainer A; Voza A; Blasi F
    Semin Respir Crit Care Med; 2024 Apr; 45(2):266-273. PubMed ID: 38395062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.
    Viasus D; Di Yacovo S; Garcia-Vidal C; Verdaguer R; Manresa F; Dorca J; Gudiol F; Carratalà J
    Medicine (Baltimore); 2013 Jan; 92(1):51-60. PubMed ID: 23266795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit.
    Cavallazzi R; Wiemken T; Arnold FW; Luna CM; Bordon J; Kelley R; Feldman C; Chalmers JD; Torres A; Ramirez J
    Respir Med; 2015 Jun; 109(6):743-50. PubMed ID: 25956021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survey on the use of glucocorticoids in severe community-acquired pneumonia in intensive care unit of forty-five hospitals in Zhejiang Province].
    Chen G; Hu W; Xuan N; Fan H; Zhu J; Cui W; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Apr; 31(4):488-492. PubMed ID: 31109427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of community-acquired pneumonia in western Saudi Arabia: A four-year retrospective analysis of medical records.
    Farahat FM; Bukhari OK; Basfar IA; Alammari AM; Zaatari AZ; Alsaedi AA; Alshamrani MM
    J Infect Public Health; 2021 Jul; 14(7):960-966. PubMed ID: 34130120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis.
    Reyes LF; Garcia E; Ibáñez-Prada ED; Serrano-Mayorga CC; Fuentes YV; Rodríguez A; Moreno G; Bastidas A; Gómez J; Gonzalez A; Frei CR; Celi LA; Martin-Loeches I; Waterer G
    Crit Care; 2023 May; 27(1):212. PubMed ID: 37259125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Older Adult Patients Surviving to Discharge.
    Corrales-Medina VF; van Walraven C
    Chest; 2023 Jun; 163(6):1380-1389. PubMed ID: 36621760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.
    Marrie TJ; Shariatzadeh MR
    Medicine (Baltimore); 2007 Mar; 86(2):103-111. PubMed ID: 17435590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.